logo-loader

Open Orphan signs UK government contract to development COVID-19 Human Challenge Study Model

Published: 14:46 20 Oct 2020 BST

Open Orphan's (LON:ORPH) Chairman Cathal Friel talks to Proactive London after announcing a contract with the UK Government for the development of a COVID-19 human challenge study model.

Friel explains that the company, hVIVO, is the world's leader in this sector, having safely run more human challenge studies than any other company globally.

The contract starts immediately and could be worth approximately £10 million to hVIVO depending upon the final number of volunteers that are included in the characterisation study.

He explains that the Government has secured the first three slots to test vaccines using hVIVO's COVID-19 challenge study, which he expects to start in 2021, at a cost of £2.5m each bringing the total value of these slot reservations to £7.5m.

hVIVO chairman Cathal Friel says he remains committed to hVIVO following...

hVIVO PLC (AIM:HVO) chairman Cathal Friel joined Proactive's Stephen Gunnion to discuss the sale of shares in hVIVO PLC by directors, including himself. Friel explained his decision to sell a portion of his shares in hVIVO was to accommodate the high demand from major institutions while...

on 19/2/24